Cyclosporin in Rheumatoid Arthritis: Monitoring for Adverse Effects and Clinically Significant Drug Interactions

ISSN： 1173-8804

Source： BioDrugs, Vol.10, Iss.6, 1998-12, pp. : 437-445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Drug Targets in Rheumatoid Arthritis: Focus on Chemokines

By Shadidi K.R.

BioDrugs, Vol. 18, Iss. 3, 2004-01 ,pp. : 181-187

Adis International

Access to resources Recommend Favorite

Spotlight on Etanercept in Rheumatoid Arthritis, Psoriatic Arthritis and Juvenile Rheumatoid Arthritis This Spotlight is derived from abstract and summary text of an Adis Drug Evaluation originally published in full in Drugs 2002; 62 (17): 2493-2537.

By Culy C.R. Keating G.M.

BioDrugs, Vol. 17, Iss. 2, 2003-01 ,pp. : 139-145

Adis International

Access to resources Recommend Favorite

Rituximab: In Rheumatoid Arthritis

By Frampton James E. Scott Lesley J.

BioDrugs, Vol. 21, Iss. 5, 2007-01 ,pp. : 333-341

Adis International

Access to resources Recommend Favorite

Abatacept for rheumatoid arthritis

By Rojahn Ruth

International Journal of Evidence-based Healthcare, Vol. 9, Iss. 4, 2011-12 ,pp. : 456-457

Blackwell Publishing

Access to resources Recommend Favorite

Certolizumab Pegol: In Rheumatoid Arthritis

By Duggan Sean T. Keam Susan J.

BioDrugs, Vol. 23, Iss. 6, 2009-12 ,pp. : 407-417

Adis International

Access to resources Recommend Favorite